Monthly information related to total number of voting rights and shares composing the share capital – October 8, 2024
Rhea-AI Summary
PHAXIAM Therapeutics has released its monthly update on voting rights and share capital as of October 8, 2024. The company's total number of shares composing the share capital stands at 10,013,719. The total number of gross (theoretical) voting rights is 10,165,848, while the total number of net voting rights (excluding treasury shares) is 10,165,599.
The report provides a historical breakdown of these figures from December 31, 2023, to October 8, 2024. Notably, there was a significant increase in the number of shares and voting rights between May 31, 2024, and July 1, 2024. The company's shares are listed on Euronext Paris (Market segment C) under the symbol PHXM with ISIN Code FR001400K4B1.
Positive
- Increase in total number of shares from 6,075,105 to 10,013,719 between May and October 2024
- Growth in gross voting rights from 6,226,989 to 10,165,848 in the same period
- Expansion of net voting rights from 6,226,740 to 10,165,599
Negative
- None.
Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)
Website : www.phaxiam.com
| Date | Total of shares composing the share capital | Total of brut (1) voting rights | Total of net (2) voting rights |
| December 31, 2023 | 6 075 105 | 6 226 982 | 6 226 733 |
| January 31, 2024 | 6 075 105 | 6 227 002 | 6 226 753 |
| February 29, 2024 | 6 075 105 | 6 226 951 | 6 226 702 |
| March 29, 2024 | 6 075 105 | 6 226 938 | 6 226 689 |
| April 30, 2024 | 6 075 105 | 6 226 932 | 6 226 683 |
| May 31, 2024 | 6 075 105 | 6 226 989 | 6 226 740 |
| July 1, 2024 | 9 980 668 | 10 132 597 | 10 132 348 |
| October 8, 2024 | 10 013 719 | 10 165 848 | 10 165 599 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Attachment